DK Life Science Co., Ltd. (KOSDAQ:303810)
South Korea
· Delayed Price · Currency is KRW 3,845.00
-25.00 (-0.65%)
At close: Dec 5, 2025
DK Life Science Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Operating Revenue | 131,172 | 131,816 | 120,161 | 107,234 | 102,668 | 109,583 | Upgrade
|
| Other Revenue | -0 | - | -0 | - | - | -0 | Upgrade
|
| Revenue | 131,172 | 131,816 | 120,161 | 107,234 | 102,668 | 109,583 | Upgrade
|
| Revenue Growth (YoY) | 0.95% | 9.70% | 12.05% | 4.45% | -6.31% | 11.12% | Upgrade
|
| Cost of Revenue | 98,191 | 103,241 | 94,909 | 85,063 | 80,826 | 86,428 | Upgrade
|
| Gross Profit | 32,981 | 28,575 | 25,253 | 22,171 | 21,842 | 23,155 | Upgrade
|
| Selling, General & Admin | 14,752 | 13,995 | 13,795 | 13,833 | 13,700 | 11,115 | Upgrade
|
| Research & Development | 1,794 | 1,466 | 1,140 | 1,014 | 1,017 | 1,217 | Upgrade
|
| Amortization of Goodwill & Intangibles | 564.08 | 162.9 | 29.18 | 40.2 | 287.39 | 61.73 | Upgrade
|
| Other Operating Expenses | 283.78 | 278.48 | 289.6 | 258.83 | 256.82 | 182.93 | Upgrade
|
| Operating Expenses | 19,947 | 16,659 | 16,723 | 15,941 | 15,045 | 14,727 | Upgrade
|
| Operating Income | 13,034 | 11,916 | 8,530 | 6,230 | 6,797 | 8,428 | Upgrade
|
| Interest Expense | -1,601 | -3,395 | -4,994 | -3,620 | -2,441 | -1,379 | Upgrade
|
| Interest & Investment Income | 90.29 | 54.74 | 98.3 | 152.55 | 69.84 | 35.32 | Upgrade
|
| Currency Exchange Gain (Loss) | -1,271 | -1,687 | -124.83 | -44.41 | -212.04 | -17.97 | Upgrade
|
| Other Non Operating Income (Expenses) | -169.99 | -2,195 | 2,241 | 2,241 | -981.23 | -692.53 | Upgrade
|
| EBT Excluding Unusual Items | 10,083 | 4,694 | 5,750 | 4,959 | 3,232 | 6,373 | Upgrade
|
| Gain (Loss) on Sale of Investments | 205.25 | 49.07 | -1,670 | 321.86 | 3,236 | 347.7 | Upgrade
|
| Gain (Loss) on Sale of Assets | 88.07 | 9.63 | 749.93 | - | -34.43 | - | Upgrade
|
| Pretax Income | 10,376 | 4,753 | 4,830 | 5,281 | 6,433 | 6,721 | Upgrade
|
| Income Tax Expense | 3,648 | 2,508 | 663.28 | 1,041 | 575.2 | 2,266 | Upgrade
|
| Net Income | 6,729 | 2,245 | 4,167 | 4,239 | 5,858 | 4,455 | Upgrade
|
| Net Income to Common | 6,729 | 2,245 | 4,167 | 4,239 | 5,858 | 4,455 | Upgrade
|
| Net Income Growth | 23.87% | -46.13% | -1.71% | -27.63% | 31.49% | -29.05% | Upgrade
|
| Shares Outstanding (Basic) | 18 | 13 | 11 | 1 | 1 | 1 | Upgrade
|
| Shares Outstanding (Diluted) | 18 | 13 | 11 | 1 | 1 | 1 | Upgrade
|
| Shares Change (YoY) | -17.34% | 14.52% | 900.58% | 0.01% | -2.05% | 2.09% | Upgrade
|
| EPS (Basic) | 380.45 | 175.00 | 372.00 | 3787.00 | 5233.00 | 3980.00 | Upgrade
|
| EPS (Diluted) | 380.45 | 175.00 | 372.00 | 3787.00 | 5233.00 | 3898.00 | Upgrade
|
| EPS Growth | 49.85% | -52.96% | -90.18% | -27.63% | 34.25% | -30.50% | Upgrade
|
| Free Cash Flow | -4,837 | 6,455 | -9,398 | -20,287 | -24,739 | -15,026 | Upgrade
|
| Free Cash Flow Per Share | -273.50 | 503.21 | -839.06 | -18122.49 | -22100.17 | -13147.89 | Upgrade
|
| Gross Margin | 25.14% | 21.68% | 21.02% | 20.68% | 21.27% | 21.13% | Upgrade
|
| Operating Margin | 9.94% | 9.04% | 7.10% | 5.81% | 6.62% | 7.69% | Upgrade
|
| Profit Margin | 5.13% | 1.70% | 3.47% | 3.95% | 5.71% | 4.06% | Upgrade
|
| Free Cash Flow Margin | -3.69% | 4.90% | -7.82% | -18.92% | -24.10% | -13.71% | Upgrade
|
| EBITDA | 19,408 | 17,698 | 11,813 | 8,691 | 9,181 | 10,517 | Upgrade
|
| EBITDA Margin | 14.80% | 13.43% | 9.83% | 8.11% | 8.94% | 9.60% | Upgrade
|
| D&A For EBITDA | 6,374 | 5,782 | 3,283 | 2,461 | 2,385 | 2,089 | Upgrade
|
| EBIT | 13,034 | 11,916 | 8,530 | 6,230 | 6,797 | 8,428 | Upgrade
|
| EBIT Margin | 9.94% | 9.04% | 7.10% | 5.81% | 6.62% | 7.69% | Upgrade
|
| Effective Tax Rate | 35.15% | 52.77% | 13.73% | 19.72% | 8.94% | 33.72% | Upgrade
|
| Advertising Expenses | - | 1,866 | 2,344 | 1,748 | 1,552 | 1,315 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.